Related Experiment Videos

Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation

A P van den Berg¹, E B Haagsma, A S Gouw

¹Department of Gastroenterology & Hepatology, University Hospital, Groningen, The Netherlands.

Transplantation Proceedings

|March 27, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study.

BMC gastroenterology·2022

Immediate impact of COVID-19 on transplant activity in the Netherlands.

Transplant immunology·2020

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response.

Open forum infectious diseases·2019

['Will I receive a liver transplant in time?'; chance of survival of patients on the liver transplant waiting list].

Nederlands tijdschrift voor geneeskunde·2018

Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death.

The British journal of surgery·2017

Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?

International journal of antimicrobial agents·2017

See all related articles